Pricing
Pricing

Syndax Pharmaceuticals

COMPARE

Overview

Total Funding Amount 
$168.3M
CB Rank (Company) 
15,226
Syndax Pharmaceuticals
Syndax Pharmaceuticals is focused on developing an HDAC inhibitor for solid tumors and hematological tumors.
Categories 
Biotechnology, Clinical Trials, Pharmaceutical
Headquarters Regions 
Greater Boston Area, East Coast, New England
Founded Date 
2005
Founders 
Peter Ordentlich
Operating Status 
Active
Funding Status 
IPO
Last Funding Type 
Series C
Number of Employees 
51-100
Legal Name 
Syndax Pharmaceuticals, Inc.
IPO Status 
Public
Stock Symbol 
NASDAQ:SNDX
Company Type 
For Profit
Website 
www.syndax.com
Facebook 
View on Facebook
Twitter 
View on Twitter
Contact Email 
info@syndax.com
Phone Number 
(185) 879-2799

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Find your next opportunity with Crunchbase Pro + Data Boost

  • Advanced Search - Find prospects with 200+ premium search filters
  • Premium Insights - View competitors, tech stack, IT spend and more
  • Monitor & Track - Get automatic email alerts on opportunities

IPO & Stock Price

Syndax Pharmaceuticals is registered under the ticker NASDAQ:SNDX
.
Stock Symbol 
NASDAQ:SNDX
Money Raised at IPO 
$53M
IPO Date 
Mar 3, 2016

Funding Rounds

Number of Funding Rounds 
7
Total Funding Amount 
$168.3M
Syndax Pharmaceuticals has raised a total of $168.3M in funding over 7 rounds. Their latest funding was raised on Aug 24, 2015 from a Series C round.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Aug 24, 2015
Series C - Syndax Pharmaceuticals
12$80M Delos Capital
Sep 18, 2014
Debt Financing - Syndax Pharmaceuticals
$4.9M
Feb 13, 2014
Venture Round - Syndax Pharmaceuticals
$1.7M
Aug 27, 2013
Series B - Syndax Pharmaceuticals
4$26.6M
Apr 5, 2010
Debt Financing - Syndax Pharmaceuticals
$6M
Mar 16, 2010
Series A - Syndax Pharmaceuticals
5$9M Domain Associates, MPM Capital
Apr 3, 2007
Series A - Syndax Pharmaceuticals
5$40M Domain Associates, MPM Capital

Investors

Related Hubs

Company Tech Stack by Siftery

Syndax Pharmaceuticals uses 8 technology products and services including Google AnalyticsWordPress, and nginx.

Website Tech Stack by BuiltWith

Syndax Pharmaceuticals is actively using 35 technologies for its website. These include Viewport MetaIPhone / Mobile Compatible, and SPF.

Web Traffic by SimilarWeb

Syndax Pharmaceuticals is ranked 4,716,089 among websites globally based on its 3,605 monthly web visitors.

Interest Signals by Bombora

Syndax Pharmaceuticals employees are showing high interest in Graphics Interchange Format (GIF)Video Hosting, and Mandiant.

Competitors & Revenue by Owler

IT Spend by Aberdeen

Current Team

Number of Current Team Members 
4
Syndax Pharmaceuticals has 4 current team members, including President & Chief Operating Officer Michael A. Metzger.
Michael A. Metzger
President & Chief Operating Officer
Peter Ordentlich
CTO and Co-Founder

Board Members and Advisors

Number of Board Members / Advisors 
3
Syndax Pharmaceuticals has 3 board members and advisors, including Dennis Podlesak.
Dennis Podlesak
Board Member
Kim P. Kamdar
Board Member

Past Team

Number of Past Team Members 
3
Syndax Pharmaceuticals has 3 past team members, including CEO Arlene M. Morris.
Person Name  
Title At Company  
Start Date  
End Date  
Arlene M. Morris
CEOMar 2012May 12, 2015
Lori Kunkel
Team Member
Caryn Peterson
Led Worldwide Regulatory Affairs

Recent News & Activity

Number of Articles 
34
Date
Activity

Twitter

Sign up for a free Crunchbase account to follow and track profiles you care about.


Terms of Service | Privacy Policy | © 2019 Crunchbase Inc. All Rights Reserved.